Capmatinib produced by Lucius,200mg*60 tablets:$525.
The price of Capmatinib may be affected by factors such as exchange rates, shipping costs, and production costs.
Capmatinib is a targeted therapy for patients with non-small cell lung cancer wi···【more】
Release date:2024-08-06Recommended:131
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyro···【more】
Release date:2024-08-06Recommended:134
Capmatinib inhibits the growth of cancer cells caused by specific genetic varian···【more】
Release date:2024-08-06Recommended:133